Heidi J.A. Wallweber

4.4k citations

21 papers · 2.5k indexed · 1 hit paper · h-index 19

Molecular Biology top 5%
Immunology top 5%
Oncology top 5%
Cancer Research top 5%
Cellular and Molecular Neuroscience top 10%

Co-authors: Kurt Deshayes Domagoj Vucic Wayne J. Fairbrother Eugene Varfolomeev Kerry Zobel Linda O. Elliott Patrick J. Lupardus John A. Flygare
Topics: Synthesis and biological activity (5 papers)Cytokine Signaling Pathways and Interactions (5 papers)Cancer Mechanisms and Therapy (3 papers)
Cited by: Immunology Cancer Research Oncology
Journals: Science Cell Proceedings of the National Academy of Sciences
Partner nations: United States France Russia

In The Last Decade

Heidi J.A. Wallweber

21 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

2007 1.0k citations Eugene Varfolomeev, John W. Blankenship et al. Cell profile →

Peers

Countries citing papers authored by Heidi J.A. Wallweber

Since Specialization

Citations

This map shows the geographic impact of Heidi J.A. Wallweber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi J.A. Wallweber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi J.A. Wallweber more than expected).

Fields of papers citing papers by Heidi J.A. Wallweber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi J.A. Wallweber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi J.A. Wallweber. The network helps show where Heidi J.A. Wallweber may publish in the future.

Co-authorship network of co-authors of Heidi J.A. Wallweber

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi J.A. Wallweber. A scholar is included among the top collaborators of Heidi J.A. Wallweber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi J.A. Wallweber. Heidi J.A. Wallweber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation 2018 ·eLife ·Ryan Ferrao,Heidi J.A. Wallweber,Patrick J. Lupardus	42
2	A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain 2017 ·Neuropharmacology ·Tzu-Ming Wang,Brandon M. Brown,Lunbin Deng,Benjamin D. Sellers,Patrick J. Lupardus,Heidi J.A. Wallweber,Amy Gustafson,Evera Wong,Matthew Volgraf,Jacob B. Schwarz,David H. Hackos,Jesse E. Hanson	32
3	Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability 2017 ·Journal of Medicinal Chemistry ·Xiaojing Wang,Aleksandr Kolesnikov,Suzanne Tay,Grace Chan,Qi Chao,Steven Do,Jason Drummond,Allen Ebens,Ning Liu,Justin Q. Ly,Eric B. Harstad,Huiyong Hu,John G. Moffat,Veerendra Munugalavadla,Jeremy Murray,Dionysos Slaga,Vickie Tsui,Matthew Volgraf,Heidi J.A. Wallweber,Jae H. Chang	19
4	Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function 2016 ·Neuron ·David H. Hackos,Patrick J. Lupardus,Teddy Grand,Yelin Chen,Tzu-Ming Wang,Paul Reynen,Amy Gustafson,Heidi J.A. Wallweber,Matthew Volgraf,Benjamin D. Sellers,Jacob B. Schwarz,Pierre Paoletti,Morgan Sheng,Qiang Zhou,Jesse E. Hanson	139
5	The Structural Basis for Class II Cytokine Receptor Recognition by JAK1 2016 ·Structure ·Ryan Ferrao,Heidi J.A. Wallweber,Hoangdung Ho,Christine Tam,Yvonne Franke,John G. Quinn,Patrick J. Lupardus	57
6	Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Huiyong Hu,Xiaojing Wang,(unknown),Jae H. Chang,Steven Do,(unknown),Allen Ebens,Wendy Lee,Justin Q. Ly,Joseph P. Lyssikatos,Jeremy Murray,John G. Moffat,Qi Chao,Vickie Tsui,Heidi J.A. Wallweber,Aleksandr Kolesnikov	19
7	Structural basis of recognition of interferon-α receptor by tyrosine kinase 2 2014 ·Nature Structural & Molecular Biology ·Heidi J.A. Wallweber,Christine Tam,Yvonne Franke,Melissa A. Starovasnik,Patrick J. Lupardus	111
8	Structure of the pseudokinase–kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition 2014 ·Proceedings of the National Academy of Sciences ·Patrick J. Lupardus,Mark Ultsch,Heidi J.A. Wallweber,Pawan Bir Kohli,Adam R. Johnson,Charles Eigenbrot	155
9	Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design 2013 ·Bioorganic & Medicinal Chemistry Letters ·Xiaojing Wang,Steven Magnuson,(unknown),(unknown),Huiyong Hu,Vickie Tsui,Wei Deng,Jeremy Murray,Micah Steffek,Heidi J.A. Wallweber,John G. Moffat,Jason Drummond,Grace Chan,Eric B. Harstad,Allen Ebens	55
10	The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site 2012 ·Structure ·(unknown),Krista K. Bowman,Jianwen A. Feng,Terry D. Crawford,Christine Everett,Yvonne Franke,Angela Oh,Mark Stanley,Steven T. Staben,Melissa A. Starovasnik,Heidi J.A. Wallweber,Jian Wu,Lawren C. Wu,Adam R. Johnson,S.G. Hymowitz	50
11	Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination 2011 ·Science ·Erin C. Dueber,Allyn J. Schoeffler,Andreas Lingel,J. Michael Elliott,Anna Fedorova,Anthony M. Giannetti,Kerry Zobel,Brigitte Maurer,Eugene Varfolomeev,Ping Wu,Heidi J.A. Wallweber,S.G. Hymowitz,Kurt Deshayes,Domagoj Vucic,Wayne J. Fairbrother	169
12	Multiple Novel Classes of APRIL-specific Receptor-blocking Peptides Isolated by Phage Display 2009 ·Journal of Molecular Biology ·Nathaniel C. Gordon,Samantha Lien,Jeremy Johnson,Heidi J.A. Wallweber,Thuy Tran,(unknown),Mary Mathieu,Clifford Quan,Melissa A. Starovasnik,S.G. Hymowitz,Robert F. Kelley	7
13	IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosisbreakdown → 2007 ·Cell ·Eugene Varfolomeev,John W. Blankenship,(unknown),Anna Fedorova,Nobuhiko Kayagaki,Parie Garg,Kerry Zobel,Jasmin N. Dynek,Linda O. Elliott,Heidi J.A. Wallweber,John A. Flygare,Wayne J. Fairbrother,Kurt Deshayes,Vishva M. Dixit,Domagoj Vucic	1013
14	Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells 2006 ·Blood ·Chingwei V. Lee,S.G. Hymowitz,Heidi J.A. Wallweber,Nathaniel C. Gordon,Karen L. Billeci,Siao‐Ping Tsai,Deanne M. Compaan,(unknown),Qian Gong,Robert F. Kelley,Laura DeForge,Flavius Martin,Melissa A. Starovasnik,Germaine Fuh	48
15	Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs 2006 ·ACS Chemical Biology ·Kerry Zobel,Lan Wang,Eugene Varfolomeev,Matthew C. Franklin,Linda O. Elliott,Heidi J.A. Wallweber,(unknown),John A. Flygare,Domagoj Vucic,Wayne J. Fairbrother,Kurt Deshayes	148
16	Correction: Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs 2006 ·ACS Chemical Biology ·Kerry Zobel,Lan Wang,Eugene Varfolomeev,Matthew C. Franklin,Linda O. Elliott,Heidi J.A. Wallweber,(unknown),John A. Flygare,Domagoj Vucic,Wayne J. Fairbrother,Kurt Deshayes	3
17	Engineering an APRIL-specific B Cell Maturation Antigen 2004 ·Journal of Biological Chemistry ·Darshana Patel,Heidi J.A. Wallweber,Jianping Yin,Stephanie Shriver,Scot A. Marsters,Nathaniel C. Gordon,Melissa A. Starovasnik,Robert F. Kelley	50
18	Structures of APRIL-Receptor Complexes 2004 ·Journal of Biological Chemistry ·S.G. Hymowitz,Darshana Patel,Heidi J.A. Wallweber,(unknown),Minhong Yan,Jianping Yin,Stephanie Shriver,Nathaniel C. Gordon,Borlan Pan,Nicholas J. Skelton,Robert F. Kelley,Melissa A. Starovasnik	126
19	The Crystal Structure of A Proliferation-inducing Ligand, APRIL 2004 ·Journal of Molecular Biology ·Heidi J.A. Wallweber,Deanne M. Compaan,Melissa A. Starovasnik,S.G. Hymowitz	49
20	The Crystal Structures of EDA-A1 and EDA-A2 2003 ·Structure ·S.G. Hymowitz,Deanne M. Compaan,Minhong Yan,Heidi J.A. Wallweber,Vishva M. Dixit,Melissa A. Starovasnik,Abraham M. de Vos	80

About Heidi J.A. Wallweber

Heidi J.A. Wallweber is a scholar working on Pharmacology, Immunology and Immunology and Allergy, having authored 21 papers that have together received 2.5k indexed citations. Recurring topics across this work include Synthesis and biological activity (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Immunology (855 citations), Cancer Research (471 citations) and Oncology (692 citations). Heidi J.A. Wallweber has collaborated with scholars based in United States, France and Russia. Frequent co-authors include Kurt Deshayes, Domagoj Vucic, Wayne J. Fairbrother, Eugene Varfolomeev, Kerry Zobel, Linda O. Elliott, Patrick J. Lupardus, John A. Flygare, Anna Fedorova and Vishva M. Dixit. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact